v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 384,985 $ 177,695
Investment securities, available-for-sale 571,489 641,991
Accounts receivable, net 150,642 121,457
Interest and other receivables 15,688 26,774
Inventory 32,372 34,670
Prepaid expenses and other current assets 69,369 59,526
Total current assets 1,224,545 1,062,113
Property and equipment, net 17,107 7,511
Operating lease right-of-use assets 69,424 47,354
Intangible assets, net 103,448 108,893
Restricted cash 7,846 7,845
Long-term inventory 76,301 76,704
Deferred tax assets 240,679 249,879
Other assets 3,550 3,896
Total assets 1,742,900 1,564,195
Liabilities and stockholders’ equity    
Accounts payable 44,566 10,903
Accrued liabilities 316,870 266,211
Total current liabilities 361,436 277,114
Operating lease liabilities 59,547 40,554
Other long-term liabilities 15,308 19,137
Total liabilities 436,291 336,805
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at June 30, 2026 and December 31, 2025; no shares issued and outstanding at June 30, 2026 and December 31, 2025 0 0
Common stock, $0.0001 par value; 225,000,000 shares authorized at June 30, 2026 and December 31, 2025; 172,132,442 shares and 170,309,376 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively 16 16
Additional paid-in capital 3,085,800 3,039,315
Accumulated deficit (1,778,249) (1,813,386)
Accumulated other comprehensive (loss) income (958) 1,445
Total stockholders’ equity 1,306,609 1,227,390
Total liabilities and stockholders’ equity $ 1,742,900 $ 1,564,195